Rybrevant
NDC 57894-501 · Janssen Biotech, Inc.
Generic nameamivantamab-vmjw
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)AMIVANTAMAB
Strength350 mg/1
Marketing categoryBLA
Packages
57894-501-01 — 1 VIAL, SINGLE-USE in 1 CARTON (57894-501-01) / 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00)
Billed under HCPCS
J9061 — Injection, amivantamab-vmjw, 2 mg Medicare Part B payment limit (ASP + 6%): $23.22
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
57894-510 — AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT), 57894-514 — AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT), 57894-515 — AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT), 57894-522 — AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)